Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment

Abstract

Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an ultra-rare disease caused by mutations in TYMP, the gene encoding for the enzyme thymidine phosphorylase. The resulting enzyme deficiency leads to a systemic accumulation of thymidine and 2’-deoxyuridine and ultimately mitochondrial failure due to a progressive acquisition of secondary mitochondrial DNA (mtDNA) mutations and mtDNA depletion. MNGIE is characterised by gastrointestinal dysmotility, cachexia, peripheral neuropathy, ophthalmoplegia, ptosis and leukoencephalopathy. The disease is progressively degenerative and leads to death at an average age of 37.6 years. Patients invariably encounter misdiagnoses, diagnostic delays, and non-specific clinical management. Despite its rarity, MNGIE has invoked much interest in the development of therapeutic strategies, mainly because it is one of the few mitochondrial disorders where the molecular abnormality is metabolically and physically accessible to manipulation. This review provides a résumé of the current diagnosis and treatment approaches and aims to increase the clinical awareness of MNGIE and thereby facilitate early diagnosis and timely access to treatments, before the development of untreatable and irreversible organ damage.

Keywords

Mitochondrial neurogastrointestinal encephalomyopathy / MNGIE / thymidine phosphorylase / TYMP / mitochondrial DNA / mitochondrial disease

References

[1] Nishino I,Hirano M.Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder..Science1999;283:689-92

[2] Hirano M,Martí R.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes..Neurologist2004;10:8-17

[3] Okamura K,Nagae K.Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria..J Neurol Sci1976;27:79-91

[4] Ionasescu V.Oculogastrointestinal muscular dystrophy..Am J Med Genet1983;15:103-12

[5] Ionasescu V,Ionasescu R,Anuras S.Inherited ophthalmoplegia with intestinal pseudo-obstruction..J Neurol Sci1983;59:215-28

[6] Ionasescu V V,Aschenbrener C,Risk WS.Late-onset oculogastrointestinal muscular dystrophy..Am J Med Genet1984;18:781-8

[7] Bardosi A,DiMauro S,Friede RL.Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase..Acta Neuropathol1987;74:248-258

[8] Faber J,Steinberg A,Granot E.Familial intestinal pseudoobstruction dominated by a progressive neurologic disease at a young age..Gastroenterology1987;92:786-90

[9] Hirano M,Blake DM,Minetti C.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder..Neurology1994;44:721-7

[10] Nishino I,Papadimitriou A,Steiner I.Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations..Ann Neurol2000;47:792-800

[11] Spinazzola A,Nishino I,Naini A.Altered thymidine metabolism due to defects of thymidine phosphorylase..J Biol Chem2002;277:4128-33

[12] Martí R,Hirano M.Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency..Biochem Biophys Res Commun2003;303:14-8

[13] Martí R,Tadesse S,Nishigaki Y.Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays..Clin Chem2004;50:120-4

[14] Valentino ML,Tadesse S,Manes JL.Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)..FEBS Lett.2007;581:3410-4 PMCID:PMC1986782

[15] Filosto M,Tonin P,Cotelli MS.Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy..J Inherit Metab Dis2011;34:1199-203

[16] Garone C,Hirano M.Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy..Brain2011;134:3326-32 PMCID:PMC3212717

[17] Prevalence and incidence of rare diseases: bibliographic data. Available from: www.orpha.net [Last accessed on 3 Mar 2020]

[18] Santoshkumar B,Radhakrishnan K.Mitochondrial neurogastrointestinal encephalopathy (MNGIE) in a South Indian family with two affected siblings..Neurol India1997;45:87-90

[19] Nishino I,Hirano M.MNGIE: from nuclear DNA to mitochondrial DNA..Neuromuscul Disord2001;11:7-10

[20] Kintarak J,Sangruchi T,Kulkantrakorn K.A novel ECGF1 mutation in a Thai patient with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)..Clin Neurol Neurosurg2007;109:613-6

[21] Carod-Artal FJ,Lara MC,Ruiz-Pesini E.Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation..Eur J Neurol2007;14:581-5

[22] Borhani Haghighi A,Sass JO,Lankarani KB.Mitochondrial neurogastrointestinal encephalomyopathy..Arch Iran Med2009;12:588-90

[23] Bariş Z,Dalgiç B,Hasanoğlu A.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): case report with a new mutation..Eur J Pediatr2010;169:1375-8

[24] Wang HF,Wang YL,Mo GL.A novel thymidine phosphorylase mutation in a Chinese MNGIE patient..Acta Neurol Belg2017;117:259-67

[25] Falcão de Campos C,Roque R,de Carvalho M.Mitochondrial neurogastrointestinal encephalomyopathy: novel pathogenic mutation in thymidine phosphorylase gene in a patient from cape verde islands..Case Rep Neurol Med2019;2019:5976410 PMCID:PMC6927060

[26] Lara MC,Torres-Torronteras J,Martí R.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches..Biosci Rep2007;27:151-63

[27] Taanman JW,Albrecht J,Mallam EA.Characterization of a novel TYMP splice site mutation associated with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)..Neuromuscul Disord2009;19:151-4

[28] Martí R,Buchman A,Tadesse S.Late-onset MNGIE due to partial loss of thymidine phosphorylase activity..Ann Neurol2005;58:649-52

[29] Massa R,Margollicci M,Tadesse S.Late-onset MNGIE without peripheral neuropathy due to incomplete loss of thymidine phosphorylase activity..Neuromuscul Disord2009;19:837-40

[30] Demaria F,Caramadre AM,Diamanti A.Mitochondrial neurogastrointestinal encephalomyopathy presenting as anorexia nervosa..J Adolesc Heal2016;59:729-31

[31] Imperatore N,Gerbino N,Rispo A.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) mimicking refractory celiac disease..Dig Liver Dis2017;49:1061-2

[32] Nagata JM.Mitochondrial neurogastrointestinal encephalomyopathy in the differential diagnosis of eating disorders..J Adolesc Heal2017;61:661

[33] Kučerová L,Dastych M,Honzík T.Mitochondrial neurogastrointestinal encephalomyopathy imitating Crohn’s disease: a rare cause of malnutrition..J Gastrointest Liver Dis2018;27:321-5

[34] Bedlack RS,Hammans S,Myers B.MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy..Muscle Nerve2004;29:364-8

[35] Said G,Planté-Bordeneuve V,Slama A.Clinicopathological aspects of the neuropathy of neurogastrointestinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation..J Neurol2005;252:655-62

[36] Needham M,Hammond S,Hirano M.Mitochondrial disease mimicking Charcot-Marie tooth disease..J Neurol Neurosurg Psychiatry2007;78:99-100 PMCID:PMC2117777

[37] Shaibani A,Zhang S,Lichtarge O.Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B..Arch Neurol2009;66:1028-32 PMCID:PMC2747647

[38] Prasun P.Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype in a patient with a novel heterozygous POLG mutation..J Neurol2014;261:1818-9

[39] Simon LT,Dorfman LJ,Herrick MK.Polyneuropathy, ophthalmoplegia, leukoencephalopathy, and intestinal pseudo-obstruction: POLIP syndrome..Ann Neurol1990;28:349-60

[40] Papadimitriou A,Hadjigeorgiou GM,Sciacco M.Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome..Neurology1998;51:1086-92

[41] Chapman TP,Fratter C,Bax BE.Unexplained gastrointestinal symptoms: think mitochondrial disease..Dig Liver Dis2014;46:1-8

[42] Scarpelli M,Zombor M,Zappini F.Poor outcome in a mitochondrial neurogastrointestinal encephalomyopathy patient with a novel TYMP mutation: the need for early diagnosis..Case Rep Neurol2012;4:248-53 PMCID:PMC3551392

[43] Çoban G,Yildirim E,Horasanli B.Mitochondrial neurogastrointestinal encephalomyopathy: imaging and clinical findings in three patients..Diagnostic Interv Radiol2013;19:191-4

[44] Mueller LA,Emslie-Smith AM.Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features..Gastroenterology1999;116:959-63

[45] Teitelbaum JE,Nurko S,Perez-Atayde AR.Diagnosis and management of MNGIE syndrome in children: case report and review of the literature..J Pediatr Gastroenterol Nutr2002;35:377-83

[46] Halter J,Casali C,Fay K.Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach..Bone Marrow Transplant2011;46:330-7 PMCID:PMC4578692

[47] Schüpbach WMM,Schaller A,Kappeler L.Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features..J Neurol2007;254:146-53

[48] Moran NF,Muqit MMK.Carrier erythrocyte entrapped thymidine phosphorylase therapy for mngie..Neurology2008;71:686-8

[49] Laforce R Jr,Dupré N,Turgeon AF.A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy..Clin Neurol Neurosurg2009;111:691-4

[50] Oztas E,Onder F,Oguz D.Chronic intestinal pseudo-obstruction and neurological manifestations in early adulthood: considering MNGIE syndrome in differential diagnosis..J Gastrointestin Liver Dis2010;19:195-7

[51] Li JN,Ji F,Wu N.Successful cochlear implantation in a patient with MNGIE syndrome..Acta Otolaryngol2011;131:1012-6

[52] Dreznik Y,Weiss B.Mitochondrial neuro-gastrointestinal encephalomyopathy presenting with recurrent bowel perforations and intra-abdominal abscesses..J Gastrointest Surg2014;18:2054-6

[53] Vondráčková A,Kratochvílová H,Vinšová K.Large copy number variations in combination with point mutations in the TYMP and SCO2 genes found in two patients with mitochondrial disorders..Eur J Hum Genet2014;22:431-4 PMCID:PMC3925276

[54] Kalkan IH,Evcimen S,Öztaş E.Spontaneous abdominal esophageal perforation in a patient with mitochondrial neurogastrointestinal encephalomyopathy..Acta Clin Belg2015;70:44-5

[55] Peedikayil MC,Abufarhaneh E,Alzahrani HA.Mitochondrial neurogastrointestinal encephalomyopathy treated with stem cell transplantation: A case report and review of literature..Hematol Oncol Stem Cell Ther2015;8:85-90

[56] Hirano M.Adam MP,Pagon RA.Gene Reviews (Internet).1993-2020;Seattle (WA)University of Washington, Seattle, 1993-2020

[57] Scarpelli M,Beltramello A,Calabria F.The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy..Neuroradiol J2013;26:520-30 PMCID:PMC4202835

[58] Gramegna LL,Testa C,D’Angelo R.Cerebral mitochondrial microangiopathy leads to leukoencephalopathy in mitochondrial neurogastrointestinal encephalopathy..Am J Neuroradiol2018;39:427-34

[59] Cardaioli E,Malfatti E,Gallus GN.A second MNGIE patient without typical mitochondrial skeletal muscle involvement..Neurol Sci2010;31:491-4

[60] Yadak R,van Gisbergen MW,de Coo IF.Mitochondrial neurogastrointestinal encephalomyopathy caused by thymidine phosphorylase enzyme deficiency: from pathogenesis to emerging therapeutic options..Front Cell Neurosci2017;11:31 PMCID:PMC5309216

[61] Yolcu M,Kaya Z,Sezen Y.Endocarditis in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome: the first in the literature..J Clin Diagn Res2014;8:SD01-2 PMCID:PMC4253249

[62] Li KM,Clarke SJ.Rapid quantitation of plasma 2’-deoxyuridine by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry and its application to pharmacodynamic studies in cancer patients..J Chromatogr B Analyt Technol Biomed Life Sci2005;820:121-30

[63] La Marca G,Casetta B,Pela I.Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS..J Mass Spectrom2006;41:586-92

[64] Mohamed S,De Giorgio R,Contin M.HPLC-UV analysis of thymidine and deoxyuridine in plasma of patients with thymidine phosphorylase deficiency..J Chromatogr B Analyt Technol Biomed Life Sci2014;949-950:58-62

[65] Fairbanks LD,Bax BE.Validation of a HPLC method for the measurement of erythrocyte encapsulated thymidine phosphorylase (EE-TP) activity..J Pharm Biomed Anal2013;76:8-12

[66] Hirano M,Quinzii CM.CoQ 10 deficiencies and MNGIE: two treatable mitochondrial disorders..Biochim Biophys Acta2012;1820:625-31 PMCID:PMC3319470

[67] Stenson PD,Ball E V,Phillips A.The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine..Hum Genet2014;133:1-9 PMCID:PMC3898141

[68] Pacitti D,Garone C,Bax BE.Mitochondrial neurogastrointestinal encephalomyopathy: into the fourth decade, what we have learned so far..Front Genet2018;9:669 PMCID:PMC6309918

[69] Kalkan IH,Oztas E,Yildiz H.A novel finding in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy): hypergonadotropic hypogonadism..Hormones (Athens)2012;11:377-9

[70] Debouverie M,Ducrocq X,Mousson B.MNGIE syndrome in 2 siblings..Rev Neurol (Paris)1997;153:547-53

[71] Nishigaki Y,Copeland WC.Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency..J Clin Invest2003;111:1913-21 PMCID:PMC161426

[72] Szigeti K,Perng CL,Eldin K.MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation..J Med Genet2004;41:125-9 PMCID:PMC1735672

[73] Çelebi N,Canbay Ö,Aypar U.Abdominal pain related to mitochondrial neurogastrointestinal encephalomyopathy syndrome may benefit from splanchnic nerve blockade..Paediatr Anaesth2006;16:1073-6

[74] Yavuz H,Christensen M,Schwartz M.Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis..Arch Neurol2007;64:435-8

[75] Granero Castro P,Moreno Gijón M,Granero Trancón J.Emergency surgery in chronic intestinal pseudo-obstruction due to mitochondrial neurogastrointestinal encephalomyopathy: case reports..Int Arch Med2010;3:35 PMCID:PMC3018369

[76] Wang J,Wang F,Qian J.Nutrition therapy for mitochondrial neurogastrointestinal encephalopathy with homozygous mutation of the TYMP gene..Clin Nutr Res2015;4:132-6 PMCID:PMC4418417

[77] Levene M,Moran N,Poulton J.Safety and efficacy of erythrocyte encapsulated thymidine phosphorylase in mitochondrial neurogastrointestinal encephalomyopathy..J Clin Med2019;8: PMCID:PMC6517976

[78] Hafez H,Abdallah M,Elakel W.Mitochondrial neurogastrointestinal encephalopathy (MNGIE) disease: a case report of a rare autosomal recessive inheritance with a poor prognosis..World J Pharm Sci2014;2:1647-51

[79] Finkenstedt A,Bösch S,Bürgi SS.Mngie syndrome: liver cirrhosis should be ruled out prior to bone marrow transplantation..JIMD Rep2013;10:41-4 PMCID:PMC3755566

[80] Taivassalo T,Argov Z,Chen J.Effects of aerobic training in patients with mitochondrial myopathies..Neurology1998;50:1055-60

[81] Yasumura S,Fujisaka M.Cochlear implantation in a patient with mitochondrial encephalopathy, lactic acidosis and stroke-like episodes syndrome..Acta Otolaryngol2003;123:55-8

[82] Hirano M,Casali C,Uldrick T.Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE..Neurology2006;67:1458-60 PMCID:PMC4345106

[83] Filosto M,Tonin P,Pavan F.Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy..J Neurol2012;259:2699-706

[84] Bax BE,Scarpelli M,Tonin P.Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement..Neurology2013;81:1269-71 PMCID:PMC3795612

[85] De Giorgio R,Rinaldi R,Caporali L.Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy..Ann Neurol2016;80:448-55

[86] Röeben B,Bender B,Haack TB.Hemodialysis in MNGIE transiently reduces serum and urine levels of thymidine and deoxyuridine, but not CSF levels and neurological function..Orphanet J Rare Dis2017;12:135 PMCID:PMC5540565

[87] Ariaudo C,Ferrero B,Burdese M.Mitochondrial neurogastrointestinal encephalomyopathy treated with peritoneal dialysis and bone marrow transplantation..J Nephrol2014;28:125-7

[88] Sivadasan A,Patil AK,Alexander M.Pearls & Oy-sters: mitochondrial neurogastrointestinal encephalomyopathy..Neurology2016;86:e147-50

[89] Chandra VS,Padmavathi Devi SVV,Sameera NS.Mitochondrial neurogastrointestinal encephalomyopathy: a nonrenal indication for peritoneal dialysis..Indian J Nephrol2018;28:310-3 PMCID:PMC6094836

[90] Salzer WL.Peritoneal dialysis-related peritonitis: Challenges and solutions..Int J Nephrol Renovasc Dis2018;11:173-86 PMCID:PMC6001843

[91] Szeto CC.Peritoneal dialysis-associated peritonitis..Clin J Am Soc Nephrol2019;14:1100-5 PMCID:PMC6625612

[92] Mihalache O,Doran H,Bobircă F.Encapsulating peritoneal sclerosis - a rare and serious complication of peritoneal dialysis: case series..J Med Life2014;7:8-12 PMCID:PMC4391411

[93] Lara MC,Illa I,Massuet L.Infusion of platelets transiently reduces nucleoside overload in MNGIE..Neurology2006;67:1461-3

[94] Hussein E.Non-myeloablative bone marrow transplant and platelet infusion can transiently improve the clinical outcome of mitochondrial neurogastrointestinal encephalopathy: a case report..Transfus Apher Sci2013;49:208-11

[95] Blumberg N,Phillips GL.Platelet transfusions: trigger, dose, benefits, and risks..F1000 Med Rep2010;2:5 PMCID:PMC2874899

[96] Godfrin Y,Franco R,Kosenko E.International seminar on the red blood cells as vehicles for drugs..Expert Opin Biol Ther2012;12:127-33 PMCID:PMC3492745

[97] Bax BE,Talbot PJ,Chalmers RA.Survival of human carrier erythrocytes in vivo..Clin Sci1999;96:171-8

[98] Bax BE,Bain MD,Filosto M.Erythrocyte encapsulated thymidine phosphorylase for the treatment of patients with mitochondrial neurogastrointestinal encephalomyopathy: study protocol for a multi-centre, multiple dose, open label trial..J Clin Med2019;8:1096 PMCID:PMC6722784

[99] Levene M,Gasson C,Sellos-Moura M.Validation of an immunoassay for anti-thymidine phosphorylase antibodies in patients with MNGIE treated with enzyme replacement therapy..Mol Ther Methods Clin Dev2018;11:1-8 PMCID:PMC6170929

[100] Halter JP,Schüpbach M,Casali C.Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy..Brain2015;138:2847-58 PMCID:PMC4836400

[101] Baker MK,Ranchhod N,van Rensburg JE.Transient clinical improvement of a mitochondrial neurogastrointestinal encephalomyopathy-like syndrome after allogeneic haematopoietic stem cell transplantation..BMJ Case Rep2017;2017: PMCID:PMC5612346

[102] Sicurelli F,Toraldo F,Bucalossi A.Clinical and biochemical improvement following HSCT in a patient with MNGIE: 1-year follow-up..J Neurol2012;259:1985-7

[103] Naymagon S,Wong SY,Renteria A.Acute graft-versus-host disease of the gut: considerations for the gastroenterologist..Nat Rev Gastroenterol Hepatol2017;14:711-26 PMCID:PMC6240460

[104] D’Angelo R,Pironi L,Pinna AD.Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy..Mitochondrion2017;34:101-2

[105] Boschetti E,Bianco F,Cenacchi G.Liver as a source for thymidine phosphorylase replacement in mitochondrial neurogastrointestinal encephalomyopathy..PLoS One2014;9:e96692 PMCID:PMC4011889

[106] Madhok J,Cohn J.Anesthetic considerations for liver transplantation in a patient with mitochondrial neurogastrointestinal encephalopathy syndrome..Cureus2019;11:e5038 PMCID:PMC6721878

[107] De Vocht C,Willaert R,Vanhaecke T.Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE..J Control Release2009;137:246-54

[108] López LC,García-Cazorla A,Martí R.Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase-deficient mice.2009;18:714-22 PMCID:PMC2638828

[109] Torres-Torronteras J,Eixarch H,Pizzorno G.Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE..Gene Ther2011;18:795-806

[110] Torres-Torronteras J,Barba I,de Luna N.Long-term restoration of thymidine phosphorylase function and nucleoside homeostasis using hematopoietic gene therapy in a murine model of mitochondrial neurogastrointestinal encephalomyopathy..Hum Gene Ther2016;27:656-67 PMCID:PMC5079415

[111] Yadak R,Van Til NP,Finkenstedt A.Transplantation, gene therapy and intestinal pathology in MNGIE patients and mice..BMC Gastroenterol2018;18:149 PMCID:PMC6194683

[112] Torres-Torronteras J,Cabrera-Pérez R,Di Meo I.Gene therapy using a liver-targeted AAV vector restores nucleoside and nucleotide homeostasis in a murine model of MNGIE..Mol Ther2014;22:901-7 PMCID:PMC4015233

[113] Torres-Torronteras J,Vila-Julià F,Cámara Y.Long-term sustained effect of liver-targeted adeno-associated virus gene therapy for mitochondrial neurogastrointestinal encephalomyopathy..Hum Gene Ther2018;29:708-18